COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
Review article
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, 치료법, 치료제,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar
[Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, 치료법, 치료제,
[키워드] acute respiratory syndrome
addition
aggravate
Asymptomatic
caused
Characteristics
chronic liver disease
cirrhosis
clinical
clinical manifestation
Complication
Coronavirus disease 2019
Coronavirus-2
COVID-19
COVID-19 patient
Critical
death
disease
dysfunction
Epidemic
extrapulmonary organs
Factors
hepatic function
Hepatocellular carcinoma
hypoxia
immune
increased risk
infection with SARS-CoV-2
inflammatory factor storms
Injury
liver
Liver damage
Liver disease
liver enzyme
Liver function
Liver injury
liver transplant
Liver transplantation
management
mechanism
nonalcoholic fatty liver
pathophysiological mechanism
Patient
patients
prevalent
public health
reperfusion
Respiratory disease
risk
SARS-CoV-2
severe disease
Stress
Treatment
Vaccine
[DOI] 10.1016/j.biopha.2022.113568 [Article Type] Review article
[DOI] 10.1016/j.biopha.2022.113568 [Article Type] Review article